Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

  • 1 November 2015 to 30 April 2016
  • Awards: Pump-priming Awards

We have traditionally used skin fibroblasts as the starting patient material for in vitro reprogramming to the iPS state but this requires a skin biopsy and subsequent time in culture to allow fibroblast outgrowth. Reprogramming peripheral blood is possible, but the best UK effort requires 60ml starting material which is not practical in most circumstances, and not possible in pediatric populations. This previous award allowed us to explore how to reprogram low volumes of peripheral human blood. Ultimately we were able to effectively progress the methodology to generate thousands of clones from 1ml of frozen adult blood.

Publications linked to this award:

  1. Chang YF, Broyles CN, Brook FA, Davies MJ, Turtle CW, et al. (2017) Non-invasive phenotyping and drug testing in single cardiomyocytes or beta-cells by calcium imaging and optogenetics. PLOS ONE 12(4): e0174181.
  2. Robinson, P., Sparrow, A., Broyles, C., Sievert, K., Chang, Y., Brook, F., Zhang, X., Watkins, H., Abassi, Y., Geeves, M., Redwood, C. and Daniels, M. (2018). Measurement of myofilament calcium in living cardiomyocytes using a targeted genetically encoded indicator. doi: